Biopsy study linking breast cancer tissue markers to treatment response
Part of Cancer, Skin clinical trials.
This study looks at breast cancer samples taken by biopsy to see how tissue “molecular markers” relate to how you respond to therapy and how the cancer behaves. It may help researchers better match future treatments to the biology of your tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer, or doctors strongly suspect it, including early or metastatic disease
- There is a body area that can be safely biopsied, and your treating doctor agrees it’s accessible
- You are age 18 or older and can sign informed consent
- Your general health is good enough for the study (ECOG 0 to 2)
- If you are on blood thinners, you may need to pause them temporarily before the biopsy (timing set by the study doctor)
- If the biopsy involves vital organs (like lung or liver), blood counts must meet minimum levels
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and stores tissue and fluid samples from people with a breast lump or breast cancer so researchers can study cancer biology in the future. It may help future patients by allowing better lab tests and research on why breast cancer starts, grows, and comes back.
This study is testing whether it is safe and practical to take multiple small tissue samples (biopsies) from different sites of your breast cancer over time. The goal is to learn how breast cancer changes as it grows, which could help doctors develop better treatments.
This study collects fresh breast-tissue biopsies from people with newly diagnosed breast cancer to learn more about how their bodies’ metabolism may affect the cancer. If you qualify, you may be asked to provide tissue samples before starting certain cancer treatments.
This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.
This study looks at why some breast cancers stop responding to treatment. It involves taking a small sample of your tumor (biopsy) and blood to understand resistance. If you have HER2-positive or triple-negative breast cancer that is growing despite treatment, you may be able to join.
This study examines tiny particles in your blood from breast cancer cells to better predict which treatments will work best for you. Researchers will collect blood samples and a small tissue sample to understand your cancer's characteristics and help doctors choose more effective therapy.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.